A61M 1/362
Changing physical properties of target cells by binding them to added particles
Official title: {changing physical properties of target cells by binding them to added particles to facilitate their subsequent separation from other cells, e.g. immunoaffinity}
A61M1/362 (Changing physical properties of target cells by binding them to added particles) appears on 124 US grants and 194 published applications in this corpus.
Search patents in A61M- Granted patents
- 124
- Published applications
- 194
- Assignees
- 82
- Inventors
- 297
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 4 | 0 |
| 1999 | 5 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 2 |
| 2002 | 2 | 3 |
| 2003 | 2 | 2 |
| 2004 | 1 | 3 |
| 2005 | 1 | 0 |
| 2006 | 0 | 2 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 6 |
| 2011 | 0 | 2 |
| 2012 | 5 | 4 |
| 2013 | 0 | 7 |
| 2014 | 1 | 14 |
| 2015 | 6 | 9 |
| 2016 | 6 | 14 |
| 2017 | 12 | 12 |
| 2018 | 6 | 15 |
| 2019 | 9 | 15 |
| 2020 | 5 | 9 |
| 2021 | 11 | 14 |
| 2022 | 2 | 18 |
| 2023 | 4 | 13 |
| 2024 | 11 | 11 |
| 2025 | 8 | 3 |
| 2026 | 6 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Device and method for administering an anti cancer substance11 Aug 2026US 12,702,739 B1
- Compounds, systems, and techniques for removal of peripheral amyloid beta peptide with albumin binding competitors12 May 2026US 12,623,013 B2Fresenius Medical Care Holdings, Inc.
- Microfluidic flow control using direct-current peristaltic pump17 Mar 2026US 12,576,194 B2The Regents of the University of Michigan
- Closed loop, bedside cell purification systems and methods10 Mar 2026US 12,569,606 B2Lupagen, Inc.
- Biocompatible nanomagnetic discs and methods of use thereof10 Feb 2026US 12,544,442 B2Accudx Corporation
- Removal of exosomes, ectosomes, mirnas, circulating nucleic acids, and viral particles with transplantation8 Oct 2026US 2026/0308567 A1Aethlon Medical, Inc.
- Devices and methods for removing cancer cells from bloodstream during cancer metastasis20 Aug 2026US 2026/0241089 A1Miracle Heart
- Modular biological cell processing system13 Aug 2026US 2026/0232888 A1Fenwal, Inc.
- Compounds, systems, and techniques for removal of peripheral amyloid beta peptide with albumin binding competitors30 Jul 2026US 2026/0216415 A1Fresenius Medical Care Holdings, Inc.
- System and method of haemodialysis4 Jun 2026US 2026/0151549 A1Captere Pty Ltd
Most cited
By later US patents
- Apparatus for separating particles194US 5,674,173 ACobe Laboratories, Inc. · 1997
- Tubing set apparatus and method for separation of fluid components192US 6,053,856 ACobe Laboratories, Inc. · 2000
- Methods, compositions, and automated systems for separating rare cells from fluid samples163US 7,166,443 B2Aviva Biosciences Corporation · 2007
- Apparatus for magnetic cell separation134US 5,536,475 ABaxter International Inc. · 1996
- Particle separation method and apparatus130US 6,071,422 ACobe Laboratories, Inc. · 2000